Home>Mutual Funds>Tata Mutual Fund>Tata India Pharma & HealthCare Fund Direct Growth
shareSHARE

Tata India Pharma & HealthCare Fund Direct Growth+1.41%

48.26%
1 Year Return
Equity
Sectoral/Thematic
2.0star
6M
1Y
3Y
5Y
All

Fund Details

Tata India Pharma & HealthCare Fund Direct Growth

RiskVery High
Min SIP Amount₹500
Expense Ratio1.19%
NAV₹17.11 (16 Apr 2021)
Fund Started28 Dec 2015
Fund Size435 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Fund Returns
48.3%
23.5%
12.2%
9.2%
Category Average
-
-
-
-
Rank Within Category
7
2
2
-
*All returns are annualized.
SIP
ONE TIME
Minimum SIP amount500
Amount Per Month₹5,000
Duration
1Y back
3Y back
5Y back
Would have become
0
with 48.3% returns per annum

Comparison

Data not available
Pros
1. 3Y Returns are higher than the category average returns
2. 5Y Returns are higher than the category average returns
Cons
1. Asset under management(AUM) is less than 500 Crs. Watch expense ratio when AUM is very low

Top Holdings

NameSectorInstrument% Assets
Dr. Reddy's Laboratories Ltd.HealthcareEquity15.1%
Sun Pharmaceutical Inds. Ltd.HealthcareEquity9.5%
Divi's Laboratories Ltd.HealthcareEquity8.7%
Cipla Ltd.HealthcareEquity8.6%
Aurobindo Pharma Ltd.HealthcareEquity7.8%
Alkem Laboratories Ltd.HealthcareEquity6.1%
Ipca Laboratories Ltd.HealthcareEquity5.5%
Fortis Healthcare Ltd.HealthcareEquity4.7%
Apollo Hospitals Enterprise Ltd.HealthcareEquity4.7%
Procter & Gamble Health Ltd.HealthcareEquity3.7%
See All

Fund Managers

Sailesh Jain
keyboard_arrow_down

Tata India Pharma & HealthCare Fund Direct Growth Details

Tata India Pharma & HealthCare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 28 Dec 2015. Rupesh Patel, Sonam Udasi is the Current Fund Manager of Tata India Pharma & HealthCare Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹435 Cr and the Latest NAV as of 16 Apr 2021 is ₹17.11.

The Tata India Pharma & HealthCare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days.

Investment Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Tax Implications

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Scheme Information Document(SID)

₹5000
Min for First Investment
₹1000
Min for Second Investment
For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days.
Exit Load

Compare Funds

Tata India Pharma & HealthCare Fund Direct Growth
VS
search

About Tata Mutual Fund

Address
Mafatlal Centre, 9th Floor, Nariman Point Mumbai 400021
Phone
022 6657 8282
Launch Date
30 Jun 1995
Website
NA
Tata Mutual Fund
Asset Management Company
Custodian
Standard Chartered Bank
Registrar & Transfer Agent
Cams
Address
7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
Loading...
Similar Funds
ⓒ 2016-2021 Groww. All rights reserved, Built with in India